Join us for an afternoon of food, music and education at the annual Swedish MS Center BBQ! We will have authentic American BBQ fare, live music by Soul Purpose Band and a talk by Dr. James Bowen, Swedish MS Center Neurologist and Medical Director.
When: Saturday, August 27, noon to 5 p.m.
A recent report has generated excitement in the scientific community. This report announces the discovery of a lymphatic system in the brain.
As someone living with multiple sclerosis and a patient of Dr. James Bowen, I wanted to share what I’ve learned about living with a wheelchair.
Undoubtedly the most talked-about study presented at the annual meeting of the American Academy of Neurology in Washington, DC, was the study of high-dose biotin for progressive MS (PPMS or SPMS). The authors conducted a randomized, double-blinded, placebo-controlled study across 16 MS centers in France, comparing placebo with MD1003, a proprietary purified high dose biotin. 154 patients participated in this 12-month study. The primary endpoint of the study was the proportion of patients who improved at 9 months (compared to the entry at the study), with sustained improvement at 12 months. 12.6% of patients in the MD1003 arm improved, compared to 0% in the placebo arm. The treated group, as a whole, had improved disability scores compared to placebo group. MD1003 was well-tolerated.